| Roche Holding AG Basel American Depositary Shares | (OP: RHHBY) |
|
63.13 USD
-0.61 (-0.96%)
|
| View: | Quote | Chart | Options | News | SEC Filings |
Ventana Introduces the BenchMark Special Stains Platform
March 19, 2012
from PR Newswire
Evidence to support DNA genotyping for HPV as a co-testing approach provided by Roche's landmark ATHENA study Read More
from PR Newswire
Ventana Receives FDA Clearance for Progesterone Receptor (1E2) Image Analysis and Digital Read Applications
March 13, 2012
from PR Newswire
from PR Newswire
Ventana Receives FDA Clearance for Ki-67 (30-9) Image Analysis and Digital Read Applications
February 27, 2012
from PR Newswire
Roche extends tender offer for Illumina
February 27, 2012
Roche and Life Technologies Corporation Sign New PCR IVD Licenses
February 22, 2012
from PR Newswire
Roche disappointed by the actions of Illumina, Inc.’s Board of Directors
February 08, 2012
Roche Receives FDA Clearance for Test to Screen and Diagnose Chlamydia and Gonorrhea Infection in Symptomatic and Asymptomatic Patients
February 01, 2012
New cobas CT/NG test expands cobas 4800 system menu beyond clinically proven HPV test to further enhance laboratory efficiency, automation capabilities Read More
from PR Newswire
Roche Enters Strategic Alliance with Technoclone to Expand Reagent Portfolio for Coagulation Diagnostics Line Targeted for US and Canada in 2014
January 26, 2012
Focus on reagents for thrombosis and cardiovascular diagnostics complements Roche plans to introduce comprehensive line of coagulation analyzers for hospital and reference labs Read More
from PR Newswire
Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy
January 17, 2012
Stratifying patients for the appropriate, targeted therapy may prove to be a significant step towards personalized medicine in cancer treatment Read More
from PR Newswire
Roche Receives Clearance From the U.S. Food and Drug Administration for the New Accu-Chek® Nano SmartView Blood Glucose Monitoring System
January 11, 2012
Innovative, small, no code device will be available to people with diabetes in the U.S. in first half of 2012 Read More
from PR Newswire
Ventana to Collaborate with Pfizer and CST on Companion Diagnostic to Identify Lung Cancer Patients with ALK Gene Rearrangements
January 10, 2012
from PR Newswire
Xenon to Collaborate with Genentech on Discovery of Novel Targeted Pain Therapeutics
January 09, 2012
from PR Newswire
Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat
January 05, 2012
from PR Newswire
Aeterna Zentaris Announces Collaboration with Ventana Medical Systems, Inc. to Develop Companion Diagnostic in Cancer for AEZS-108
January 05, 2012
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
